Vladimir E.

Vladimir E. has held various high-level positions in the pharmaceutical industry, starting as Head of Cardiology and Nuclear Medicine at PAREXEL in 2010. Vladimir then moved on to roles such as Global Medical Director at ARIAD Pharmaceuticals and Global Medical Director Neurology at Biogen. Most recently, they served as Executive Medical Director, Global Safety Lead at Veloxis Pharmaceuticals. Throughout their career, Vladimir has shown expertise in global brand strategy, clinical trial operations, and medical affairs leadership.

Vladimir E. completed a Master of Science degree in Civil Engineering at St. Petersburg State Transport University in Russia. Vladimir then went on to pursue a Doctor of Medicine degree at Lund University in Sweden, followed by a Clinical Fellowship in Nuclear Medicine at the same institution. Vladimir also completed a Doctor of Philosophy degree in Clinical Physiology and Nuclear Medicine at Lund University. Additionally, Vladimir completed post-doctoral fellowships in Imaging Cardiology at the National Institute of Health and in Nuclear Medicine Clinic at the University of California UCLA. Vladimir also engaged in a Preclinical PET Program at Hammersmith Hospital in London and a Business Economics and Trade Program in Sweden.